Global Small Molecule CXO Market Growth (Status and Outlook) 2023-2029

Global Small Molecule CXO Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Small Molecule CXO Industry Forecast” looks at past sales and reviews total world Small Molecule CXO sales in 2022, providing a comprehensive analysis by region and market sector of projected Small Molecule CXO sales for 2023 through 2029. With Small Molecule CXO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Small Molecule CXO industry.

This Insight Report provides a comprehensive analysis of the global Small Molecule CXO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Small Molecule CXO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Small Molecule CXO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Small Molecule CXO and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Small Molecule CXO.

The global Small Molecule CXO market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Small Molecule CXO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Small Molecule CXO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Small Molecule CXO is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Small Molecule CXO players cover IQVIA, Labcorp, PPD, Wuxi Apptec, PharmaBlock, Asym Chemical, Jiuzhou Pharmaceutical, Pharmaron Beijing and Porton Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Small Molecule CXO market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
CRO
CMC
CDMO
CMO

Segmentation by application
Pharmaceutical
Biopharmaceutical

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IQVIA
Labcorp
PPD
Wuxi Apptec
PharmaBlock
Asym Chemical
Jiuzhou Pharmaceutical
Pharmaron Beijing
Porton Pharma
ChemPartner
Tigermed
Shanghai Medicilon
VIVA Biotech Holdings
Chengdu Hitgen
Nanjing Genscript
ICON plc
PRA Health
Syneos Health

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Small Molecule CXO Market Size 2018-2029
2.1.2 Small Molecule CXO Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Small Molecule CXO Segment by Type
2.2.1 CRO
2.2.2 CMC
2.2.3 CDMO
2.2.4 CMO
2.3 Small Molecule CXO Market Size by Type
2.3.1 Small Molecule CXO Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Small Molecule CXO Market Size Market Share by Type (2018-2023)
2.4 Small Molecule CXO Segment by Application
2.4.1 Pharmaceutical
2.4.2 Biopharmaceutical
2.5 Small Molecule CXO Market Size by Application
2.5.1 Small Molecule CXO Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Small Molecule CXO Market Size Market Share by Application (2018-2023)
3 Small Molecule CXO Market Size by Player
3.1 Small Molecule CXO Market Size Market Share by Players
3.1.1 Global Small Molecule CXO Revenue by Players (2018-2023)
3.1.2 Global Small Molecule CXO Revenue Market Share by Players (2018-2023)
3.2 Global Small Molecule CXO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Small Molecule CXO by Regions
4.1 Small Molecule CXO Market Size by Regions (2018-2023)
4.2 Americas Small Molecule CXO Market Size Growth (2018-2023)
4.3 APAC Small Molecule CXO Market Size Growth (2018-2023)
4.4 Europe Small Molecule CXO Market Size Growth (2018-2023)
4.5 Middle East & Africa Small Molecule CXO Market Size Growth (2018-2023)
5 Americas
5.1 Americas Small Molecule CXO Market Size by Country (2018-2023)
5.2 Americas Small Molecule CXO Market Size by Type (2018-2023)
5.3 Americas Small Molecule CXO Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Small Molecule CXO Market Size by Region (2018-2023)
6.2 APAC Small Molecule CXO Market Size by Type (2018-2023)
6.3 APAC Small Molecule CXO Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Small Molecule CXO by Country (2018-2023)
7.2 Europe Small Molecule CXO Market Size by Type (2018-2023)
7.3 Europe Small Molecule CXO Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Small Molecule CXO by Region (2018-2023)
8.2 Middle East & Africa Small Molecule CXO Market Size by Type (2018-2023)
8.3 Middle East & Africa Small Molecule CXO Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Small Molecule CXO Market Forecast
10.1 Global Small Molecule CXO Forecast by Regions (2024-2029)
10.1.1 Global Small Molecule CXO Forecast by Regions (2024-2029)
10.1.2 Americas Small Molecule CXO Forecast
10.1.3 APAC Small Molecule CXO Forecast
10.1.4 Europe Small Molecule CXO Forecast
10.1.5 Middle East & Africa Small Molecule CXO Forecast
10.2 Americas Small Molecule CXO Forecast by Country (2024-2029)
10.2.1 United States Small Molecule CXO Market Forecast
10.2.2 Canada Small Molecule CXO Market Forecast
10.2.3 Mexico Small Molecule CXO Market Forecast
10.2.4 Brazil Small Molecule CXO Market Forecast
10.3 APAC Small Molecule CXO Forecast by Region (2024-2029)
10.3.1 China Small Molecule CXO Market Forecast
10.3.2 Japan Small Molecule CXO Market Forecast
10.3.3 Korea Small Molecule CXO Market Forecast
10.3.4 Southeast Asia Small Molecule CXO Market Forecast
10.3.5 India Small Molecule CXO Market Forecast
10.3.6 Australia Small Molecule CXO Market Forecast
10.4 Europe Small Molecule CXO Forecast by Country (2024-2029)
10.4.1 Germany Small Molecule CXO Market Forecast
10.4.2 France Small Molecule CXO Market Forecast
10.4.3 UK Small Molecule CXO Market Forecast
10.4.4 Italy Small Molecule CXO Market Forecast
10.4.5 Russia Small Molecule CXO Market Forecast
10.5 Middle East & Africa Small Molecule CXO Forecast by Region (2024-2029)
10.5.1 Egypt Small Molecule CXO Market Forecast
10.5.2 South Africa Small Molecule CXO Market Forecast
10.5.3 Israel Small Molecule CXO Market Forecast
10.5.4 Turkey Small Molecule CXO Market Forecast
10.5.5 GCC Countries Small Molecule CXO Market Forecast
10.6 Global Small Molecule CXO Forecast by Type (2024-2029)
10.7 Global Small Molecule CXO Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 IQVIA
11.1.1 IQVIA Company Information
11.1.2 IQVIA Small Molecule CXO Product Offered
11.1.3 IQVIA Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 IQVIA Main Business Overview
11.1.5 IQVIA Latest Developments
11.2 Labcorp
11.2.1 Labcorp Company Information
11.2.2 Labcorp Small Molecule CXO Product Offered
11.2.3 Labcorp Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Labcorp Main Business Overview
11.2.5 Labcorp Latest Developments
11.3 PPD
11.3.1 PPD Company Information
11.3.2 PPD Small Molecule CXO Product Offered
11.3.3 PPD Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 PPD Main Business Overview
11.3.5 PPD Latest Developments
11.4 Wuxi Apptec
11.4.1 Wuxi Apptec Company Information
11.4.2 Wuxi Apptec Small Molecule CXO Product Offered
11.4.3 Wuxi Apptec Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Wuxi Apptec Main Business Overview
11.4.5 Wuxi Apptec Latest Developments
11.5 PharmaBlock
11.5.1 PharmaBlock Company Information
11.5.2 PharmaBlock Small Molecule CXO Product Offered
11.5.3 PharmaBlock Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 PharmaBlock Main Business Overview
11.5.5 PharmaBlock Latest Developments
11.6 Asym Chemical
11.6.1 Asym Chemical Company Information
11.6.2 Asym Chemical Small Molecule CXO Product Offered
11.6.3 Asym Chemical Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Asym Chemical Main Business Overview
11.6.5 Asym Chemical Latest Developments
11.7 Jiuzhou Pharmaceutical
11.7.1 Jiuzhou Pharmaceutical Company Information
11.7.2 Jiuzhou Pharmaceutical Small Molecule CXO Product Offered
11.7.3 Jiuzhou Pharmaceutical Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Jiuzhou Pharmaceutical Main Business Overview
11.7.5 Jiuzhou Pharmaceutical Latest Developments
11.8 Pharmaron Beijing
11.8.1 Pharmaron Beijing Company Information
11.8.2 Pharmaron Beijing Small Molecule CXO Product Offered
11.8.3 Pharmaron Beijing Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Pharmaron Beijing Main Business Overview
11.8.5 Pharmaron Beijing Latest Developments
11.9 Porton Pharma
11.9.1 Porton Pharma Company Information
11.9.2 Porton Pharma Small Molecule CXO Product Offered
11.9.3 Porton Pharma Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Porton Pharma Main Business Overview
11.9.5 Porton Pharma Latest Developments
11.10 ChemPartner
11.10.1 ChemPartner Company Information
11.10.2 ChemPartner Small Molecule CXO Product Offered
11.10.3 ChemPartner Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 ChemPartner Main Business Overview
11.10.5 ChemPartner Latest Developments
11.11 Tigermed
11.11.1 Tigermed Company Information
11.11.2 Tigermed Small Molecule CXO Product Offered
11.11.3 Tigermed Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 Tigermed Main Business Overview
11.11.5 Tigermed Latest Developments
11.12 Shanghai Medicilon
11.12.1 Shanghai Medicilon Company Information
11.12.2 Shanghai Medicilon Small Molecule CXO Product Offered
11.12.3 Shanghai Medicilon Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Shanghai Medicilon Main Business Overview
11.12.5 Shanghai Medicilon Latest Developments
11.13 VIVA Biotech Holdings
11.13.1 VIVA Biotech Holdings Company Information
11.13.2 VIVA Biotech Holdings Small Molecule CXO Product Offered
11.13.3 VIVA Biotech Holdings Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 VIVA Biotech Holdings Main Business Overview
11.13.5 VIVA Biotech Holdings Latest Developments
11.14 Chengdu Hitgen
11.14.1 Chengdu Hitgen Company Information
11.14.2 Chengdu Hitgen Small Molecule CXO Product Offered
11.14.3 Chengdu Hitgen Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Chengdu Hitgen Main Business Overview
11.14.5 Chengdu Hitgen Latest Developments
11.15 Nanjing Genscript
11.15.1 Nanjing Genscript Company Information
11.15.2 Nanjing Genscript Small Molecule CXO Product Offered
11.15.3 Nanjing Genscript Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 Nanjing Genscript Main Business Overview
11.15.5 Nanjing Genscript Latest Developments
11.16 ICON plc
11.16.1 ICON plc Company Information
11.16.2 ICON plc Small Molecule CXO Product Offered
11.16.3 ICON plc Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.16.4 ICON plc Main Business Overview
11.16.5 ICON plc Latest Developments
11.17 PRA Health
11.17.1 PRA Health Company Information
11.17.2 PRA Health Small Molecule CXO Product Offered
11.17.3 PRA Health Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.17.4 PRA Health Main Business Overview
11.17.5 PRA Health Latest Developments
11.18 Syneos Health
11.18.1 Syneos Health Company Information
11.18.2 Syneos Health Small Molecule CXO Product Offered
11.18.3 Syneos Health Small Molecule CXO Revenue, Gross Margin and Market Share (2018-2023)
11.18.4 Syneos Health Main Business Overview
11.18.5 Syneos Health Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings